Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia

scientific article published in May 2010

Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/HEP.23515
P932PMC publication ID2946382
P698PubMed publication ID20169624
P5875ResearchGate publication ID41488258

P50authorMary CarringtonQ29840699
Stephen GangeQ37372235
Melissa FazzariQ61099538
Norah A TerraultQ61478982
Howard D StricklerQ89146137
Chloe L ThioQ92964327
James J GoedertQ92964334
Kathryn M. AnastosQ100301637
Howard L. MinkoffQ111569766
Mardge H. CohenQ112651887
Xiaojiang GaoQ114576939
Darlene MartiQ115623850
Mark H KuniholmQ115623853
P2093author name stringXiaonan Xue
Marion G Peters
Mary A Young
Ruth M Greenblatt
Andrea Kovacs
Tiffany G Harris
P2860cites workA genome-wide association study of psoriasis and psoriatic arthritis identifies new disease lociQ21145042
Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative ResearchQ22010973
HLA-Cw*04 and hepatitis C virus persistenceQ27472874
The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infectionQ27477855
Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcomeQ27486089
Host Genetic Factors and Antiviral Immune Responses to Hepatitis C VirusQ27487445
Human leukocyte antigen class II associations with hepatitis C virus clearance and virus‐specific CD4 T cell response among Caucasians and African AmericansQ27489728
Determinants of viral clearance and persistence during acute hepatitis C virus infectionQ28131757
Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDSQ28198471
A comparative review of HLA associations with hepatitis B and C viral infections across global populationsQ28299722
A whole-genome association study of major determinants for host control of HIV-1Q29614891
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002Q29619974
The global burden of hepatitis CQ29620138
Identification of two independent risk factors for lupus within the MHC in United Kingdom familiesQ30837981
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.Q34056087
HLA class II association with rheumatoid arthritis: facts and interpretationsQ34132727
Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infectionQ34700869
Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cellsQ35077992
Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitopeQ35404598
Host genetic determinants in hepatitis C virus infectionQ35753723
Hanging in the balance. KIR and their role in disease.Q36241147
Hepatitis C virus quasispecies in HIV-infected women: role of injecting drug use and highly active antiretroviral therapy (HAART)Q36427909
Impact of the genetic restriction of virus-specific T-cell responses in hepatitis C virus infectionQ36710738
Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitisQ37105244
High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patientsQ37150304
A comparison between the force of infection estimates for blood-borne viruses in injecting drug user populations across the European Union: a modelling study.Q40052601
Do we still need a cohort study of women with HIV infection?Q40866620
Meta-analysis of the association between HLA-DRB1 allele and rheumatoid arthritis susceptibility in Asian populations.Q41575362
Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in EuropeQ42981324
Hepatitis C virus (HCV)--specific T cell responses in injection drug users with apparent resistance to HCV infectionQ42982614
Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single sourceQ42986139
HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infectionQ42986755
Persistence of hepatitis C virus in a white population: associations with human leukocyte antigen class 1.Q42986786
Association between MHC class II alleles and clearance of circulating hepatitis C virus. Members of the Trent Hepatitis C Virus Study GroupQ42988856
Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research GroupQ42993140
Increased frequency of the HLA-DR15 (B1*15011) allele in German patients with self-limited hepatitis C virus infection.Q42993377
Viral clearance in hepatitis C (1b) infection: relationship with human leukocyte antigen class II in a homogeneous populationQ42998786
Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearanceQ43000404
Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses.Q43000889
Racial differences in HLA class II associations with hepatitis C virus outcomesQ43032027
Protective effect of HLA-B57 on HCV genotype 2 infection in a West African populationQ43038195
Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritisQ44037409
Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virusQ44258227
Extended human leukocyte antigen haplotype EH18.1 influences progression to hepatocellular carcinoma in patients with hepatitis C virus infection.Q44785802
Absence of association between HLA antigens and chronicity of viral hepatitis in haemodialyzed patientsQ44944774
The HLA-B*5703 allele confers susceptibility to the development of spondylarthropathies in Zambian human immunodeficiency virus-infected patients with slow progression to acquired immunodeficiency syndrome.Q45527277
Rapid transmission of hepatitis C virus among young injecting heroin users in Southern ChinaQ45654072
Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infectionQ45759756
HLA class II genes in chronic hepatitis C virus-infection and associated immunological disordersQ45766137
Major histocompatibility complex class I chain-related gene A in Thai psoriasis patients: MICA association as a part of human leukocyte antigen-B-Cw haplotypesQ47614377
Human leukocyte antigen allele associations in type-1 autoimmune hepatitis patients from western India.Q54682881
HLA-B*5703 independently associated with slower HIV-1 disease progression in Rwandan women.Q55033318
Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.Q55240560
Association between MHC Class II Alleles and Clearance of Circulating Hepatitis C VirusQ58324423
HLA class II favors clearance of HCV infection and progression of the chronic liver damageQ60023612
Meta-analysis and epidemiologic studies in drug development and postmarketing surveillanceQ74592836
Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemiaQ77169966
Natural history of hepatitis CQ80384219
AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesisQ81481381
The Women's Interagency HIV Study. WIHS Collaborative Study GroupQ95805016
P433issue5
P407language of work or nameEnglishQ1860
P921main subjecthepatitis CQ154869
Hepatitis C virusQ708693
P304page(s)1514-1522
P577publication date2010-05-01
P1433published inHepatologyQ15724398
P1476titleSpecific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia
P478volume51

Reverse relations

cites work (P2860)
Q36609717Acute and Chronic Hepatitis E Virus Infection in Human Immunodeficiency Virus-Infected U.S. Women
Q37805839Adaptive Immunity to the Hepatitis C Virus
Q35350883Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection
Q59351582Approaches, Progress, and Challenges to Hepatitis C Vaccine Development
Q40943814Association of HLA class II alleles with hepatitis C virus clearance and persistence in thalassemia patients from Iran
Q36921188Association of Hepatitis C Virus Infection With CD4/CD8 Ratio in HIV-Positive Women
Q42605390Characterisation of Mhc class I and class II DRB polymorphism in red-bellied tamarins (Saguinus labiatus).
Q35531173Compensatory mutations restore the replication defects caused by cytotoxic T lymphocyte escape mutations in hepatitis C virus polymerase
Q38010203Complete definition of immunological correlates of protection and clearance of hepatitis C virus infection: a relevant pending task for vaccine development
Q34369562DLA class II alleles and haplotypes are associated with risk for and protection from chronic hepatitis in the English Springer spaniel
Q27010312Dendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle?
Q37540482Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users
Q46500540Differential Immunodominance Hierarchy of CD8+ T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 Infection
Q43047331Early Transcriptional Divergence Marks Virus-Specific Primary Human CD8+ T Cells in Chronic versus Acute Infection
Q33796039Effect of HLA on hepatitis C virus clearance and persistence in anti-HCV-positive end-stage renal disease patients
Q58091936Exploring NS3/4A, NS5A and NS5B proteins to design conserved subunit multi-epitope vaccine against HCV utilizing immunoinformatics approaches
Q37964746Failure of innate and adaptive immune responses in controlling hepatitis C virus infection
Q33350754Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment.
Q83885557Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma
Q30590832Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts
Q45352716HLA DRB1 alleles and hepatitis C virus infection in chronic kidney disease patients.
Q36221533HLA Preferences for Conserved Epitopes: A Potential Mechanism for Hepatitis C Clearance.
Q35374519HLA-B alleles B*15:01 and B*15:02: opposite association with hepatitis C virus infection in Chinese voluntary blood donors
Q37402195HLA-B*27 subtype specificity determines targeting and viral evolution of a hepatitis C virus-specific CD8+ T cell epitope
Q43037903Hepatitis C virus replication in Caucasian HIV controllers.
Q38812892Hepatitis C-A clinical review
Q61443480High prevalence of occult hepatitis C infection in predialysis patients
Q37862746Host genetics in immune-mediated hepatitis C virus clearance
Q41935509Human Leukocyte Antigen Variants and Risk of Hepatocellular Carcinoma Modified by HCV Genotypes: A Genome-wide Association Study
Q39255932Human leucocyte antigen class I and II imputation in a multiracial population.
Q35446259Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutations
Q35275215Human leukocyte antigen genotype and risk of HIV disease progression before and after initiation of antiretroviral therapy
Q57285391Identification of a Shared Cytochrome p4502E1 Epitope Found in Anesthetic Drug-Induced and Viral Hepatitis
Q36594965Immunity and hepatitis C: a review
Q37281576Influence of IFNL3 and HLA-DPB1 genotype on postpartum control of hepatitis C virus replication and T-cell recovery
Q38364524Innate and adaptive genetic pathways in HCV infection
Q55311659KIR2DL2 combined with HLA-C1 confers risk of hepatitis C virus-related hepatocellular carcinoma in younger patients.
Q34055276KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection
Q37354049Mapping the genomic diversity of HCV subtypes 1a and 1b: Implications of structural and immunological constraints for vaccine and drug development
Q52626860Regulatory CD4+ T Cells Recognize MHC-II-Restricted Peptide Epitopes of Apolipoprotein B.
Q37046078Relation of HLA class I and II supertypes with spontaneous clearance of hepatitis C virus
Q42978256Reversal of nonstructural protein 3-specific CD4(+) T cell dysfunction in patients with persistent hepatitis C virus infection
Q37957971Role of stress-induced NKG2D ligands in liver diseases.
Q34493947Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes
Q35737580Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART).
Q37138377Synergism of tapasin and human leukocyte antigens in resolving hepatitis C virus infection
Q27003510T cell responses in hepatitis C virus infection: historical overview and goals for future research
Q37166509The Associations of HLA-A*02:01 and DRB1*11:01 with Hepatitis C Virus Spontaneous Clearance Are Independent of IL28B in the Chinese Population
Q34181287The efficiency of the human CD8+ T cell response: how should we quantify it, what determines it, and does it matter?
Q35000910The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women
Q28391462The role of HLA-DR-DQ haplotypes in variable antibody responses to anthrax vaccine adsorbed
Q35839496Update on hepatitis C virus-specific immunity
Q64122751Vaccination to prevent T cell subversion can protect against persistent hepacivirus infection

Search more.